Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties
Source abstract
Abstract
Bimodal imaging agents that combine magnetic resonance imaging (MRI) and nearinfrared (NIR) imaging formulated as nanoemulsions became increasingly popular for imaging inflammation in vivo. Quality of in vivo imaging using nanoemulsions is directly dependent on their integrity and stability. Here we report the design of nanoemulsions for bimodal imaging, where both photostability and colloidal stability are equally addressed. A highly chemically and photo stable quaterrylenediimide dye was introduced into perfluoro-15-crown-5 ether (PCE) nanoemulsions. The nanoemulsions were prepared with PCE and Miglyol 812N mixed at 1:1 v/v ratio as internal phase stabilized by non-ionic surfactants. Data shows exceptional colloidal stability demonstrated as unchanged droplet size (~130 nm) and polydispersity (<0.15) after 182 days follow up at both 4 and 25 °C. Nanoemulsions also sustained the exposure to mechanical and temperature stress, and prolonged exposure to light without changes in droplet size, (19)F signal or fluorescence signal. No toxicity was observed in vitro in model inflammatory cells upon 24 h exposure while confocal microscopy showed that nanoemulsions droplets accumulated in the cytoplasm. Overall, our data demonstrates that design of bimodal imaging agents requires consideration of stability of each imaging component and that of the nanosystem as a whole to achieve excellent imaging performance.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Proteins in Food Systems · Connective tissue disorders research · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer10.3390/ijms140815910 ↗
2. Multimodal magnetic resonance imaging in the diagnosis and therapeutical follow-up of brain tumors10.17712/1658-3183.1985 ↗
3. Multifunctional nanoparticles for multimodal imaging and theragnosis10.1039/C2CS15261D ↗
4. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics10.2217/nnm.11.14 ↗
5. Inorganic nanoparticles for multimodal molecular imaging10.2310/7290.2011.00001 ↗
6. Multimodal imaging approaches: PET/CT and PET/MRI10.1007/978-3-540-72718-7_6 ↗
7. A novel probe for the non-invasive detection of tumor-associated inflammation10.4161/onci.23034 ↗
8. Non-invasive imaging of endothelial progenitor cells in tumor neovascularization using a novel dual-modality paramagnetic/near-infrared fluorescence probe10.1371/journal.pone.0050575 ↗
9. Multifunctional Fe3O4@C@Ag hybrid nanoparticles as dual modal imaging probes and near-infrared light-responsive drug delivery platform10.1016/j.biomaterials.2012.10.002 ↗
10. Selective targeting of antibody conjugated multifunctional nanoclusters (nanoroses) to epidermal growth factor receptors in cancer cells10.1021/la200659z ↗
11. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo10.1021/bc100241a ↗
12. Combined magnetic resonance and optical imaging of head and neck tumor xenografts using Gadolinium-labelled phosphorescent polymeric nanomicelles10.1186/1758-3284-2-35 ↗
13. Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR81310.1016/j.biomaterials.2010.05.001 ↗
14. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping10.1097/RLI.0b013e31804f5a79 ↗
15. Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts10.2310/7290.2007.00006 ↗
16. A multimodal contrast agent for preoperative MR imaging and intraoperative tumor margin delineation10.1177/153303460600500401 ↗
17. Two-color fluorescent (NIR and visible) triphasic perfluorocarbon nanoemuslions10.1117/1.JBO.18.10.101312 ↗
18. Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study10.1371/journal.pone.0055802 ↗
19. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells10.1002/mrm.22702 ↗
20. In vivo cytometry of antigen-specific t cells using 19F MRI10.1002/mrm.22063 ↗
21. Second-generation perfluorocarbon emulsion blood substitutes10.3109/10731190009119783 ↗
22. Cyanines during the 1990s: a Review10.1021/cr990402t ↗
23. Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles10.1021/nn102274q ↗
24. Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles10.2217/nnm.10.38 ↗
25. Multifunctional perfluorocarbon nanoemulsions for (19)F-based magnetic resonance and near-infrared optical imaging of dendritic cells10.1039/b914006a ↗
26. NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging10.1016/j.jfluchem.2012.02.004 ↗
27. Photostable, hydrophilic and functional near infrared quaterrylenediimide-cored dendrimers for biomedical imaging10.1039/c2cc34094a ↗
28. Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions10.1007/s10456-010-9166-0 ↗
29. Interaction of melittin peptides with perfluorocarbon nanoemulsion particles10.1021/jp209543c ↗
30. On the growth mechanisms of nanoemulsions10.1016/j.jcis.2012.12.018 ↗
31. Impact of oil type on nanoemulsion formation and Ostwald ripening stability10.1021/la801685v ↗
32. Fluorine-containing nanoemulsions for MRI cell tracking10.1002/wnan.35 ↗
33. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons10.1096/fj.06-6505com ↗
34. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer10.1002/wnan.1176 ↗
35. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection10.1021/ja077388j ↗
36. Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy10.1002/wnan.126 ↗
37. Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis10.1002/wnan.9 ↗
38. Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides10.1021/nl073290r ↗
39. Nanosizing of poorly water soluble compounds using rotation/revolution mixer10.1248/cpb.57.1061 ↗
40. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions10.1016/j.jconrel.2011.01.022 ↗
41. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics10.1007/s10439-009-9643-z ↗
42. Characterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulations10.1021/jp103228c ↗
43. Janjic JM, Ahrens ET. Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications. US Patent 8,227,610 Issued July 24, 2012.
44. Quaterrylenebis(dicarboximide)s: near infrared absorbing and emitting dyes10.1039/a804337j ↗
45. 2010 · 66
46. Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets